Starship Child Health, Te Toka Tumai Auckland

• ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.

  Phase 3, Not yet recruiting, 600 people, Sep 21, 2026

• NCT06259006

  Phase 3, Recruiting, 80 people, Feb 14, 2024

Sources: clinicaltrials.gov